| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
ii
|
|
|
|
Contents
|
|
ix-xvi
|
|
| 12th Congress of the Asian Society of Transplantation |
| Advances in Kidney Transplantation |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Transplantation Proceedings - A Decade of Evolution
Transplantation Proceedings, which was founded as the voice of the Transplantation Society at its inception in Paris in 1968, has evolved over the past decade in parallel with the international expans...
|
Barry D. Kahan
|
3-5
|
|
|
|
Preface
The leading transplantation society in Asia, the Asian Society of Transplantation (AST) is an Affiliated Society of The Transplantation Society (TTS). AST has been organizing the CAST meeting biannual...
|
 Sang-Joon Kim,
 Kim Yu Seun Kim,
 Su Kil Park
|
6
|
|
| Kidney Donation |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Imaging Evaluation of Kidney Using Multidetector Computerized Tomography in Living-Related Renal Transplantation
Abstract: Background: Multidetector computerized tomography (MDCT) is lesser invasive than conventional angiography and has the advantage of assessment of vessels and surrounding anatomic variants bef...
|
C.-H. Chen,
K.-H. Shu,
C.-H. Cheng,
M.-J. Wu,
T.-M. Yu,
Y.-W. Chuang,
S.-T. Huang,
S.-W. Hung
et al.
|
7-10
|
|
|
|
The Role of Kidney Biopsy to Determine Donation from Prospective Kidney Donors with Asymptomatic Urinary Abnormalities
Abstract: Background: There are no definite guidelines about donation among prospective donors with asymptomatic urinary abnormalities. We evaluated the pathology of prospective kidney donors with asy...
|
S.R. Choi,
I.O. Sun,
Y.A. Hong,
H.G. Kim,
H.S. Park,
B.H. Chung,
B.S. Choi,
C.W. Park,
Y.S. Kim,
C.W. Yang
et al.
|
11-13
|
|
|
|
The Utilization and Advantages of an Exchange Donor Program in Living Donor Renal Transplantation: A Single-Center Experience
Abstract: Introduction: The availability of donors is a major limiting factor in living donor renal transplantation. Approximately one third of patients with end-stage renal disease have willing poten...
|
H.S. Kim,
O.J. Kwon,
C.M. Kang
|
14-16
|
|
|
|
The Role of the Altruistic Unbalanced Chain in Exchange Living Donor Renal Transplantation: Single-Center Experience
Abstract: Background: The exchange donor program in renal transplantation is an efficient solution for recipients with a blood type or crossmatch-incompatible donor. However, this program has some dif...
|
B.K. Ahn,
O.J. Kwon,
C.M. Kang
|
17-21
|
|
|
|
Comparative Outcomes of Open Nephrectomy, Hand-Assisted Laparoscopic Nephrectomy, and Full Laparoscopic Nephrectomy for Living Donors
Abstract: Objective: Kidney transplantation is a standard treatment for end-stage renal disease. There are many methods of harvesting kidneys from living donors. At present, the role of minimally inva...
|
P. Ungbhakorn,
W. Kongchareonsombat,
C. Leenanupan,
K. Kijvikai,
W. Wisetsingh,
S. Patcharatrakul,
S. Jirasiritam
et al.
|
22-25
|
|
|
|
Hand-Assisted Technique Facilitates Preserving Graft Viability in Laparoscopic Donor Nephrectomy
Abstract: Background: To achieve Patient Safety and minimal operative invasion in living kidney donor nephrectomy, we have performed hand-assisted laparoscopic donor nephrectomy (HALDoN) since 2006. A...
|
Y. Marui,
M. Nakamura,
K. Tanaka,
S. Tomikawa
|
26-29
|
|
|
|
Laparoscopic Donor Nephrectomy: Single-Center Experience
Abstract: Objective: Laparoscopic living donor nephrectomy (LLDN) has become the standard procedure for renal transplantation. This technique is considered less invasive for the donor, allowing lower ...
|
T. Hayashi,
K. Nose,
M. Nozawa,
T. Nishioka,
K. Yoshimura,
T. Ishii,
H. Uemura
et al.
|
30-31
|
|
|
|
Does Video-Assisted Minilaparotomy Surgical Living Donor Nephrectomy Satisfy Donors?
Abstract: Purpose: Video-assisted minilaparotomy surgical (VAMS) nephrectomy is believed to provide better cosmetic outcomes than open-donor nephrectomy in healthy donors. However, the results of a fe...
|
S.Y. Son,
H.M. Yang,
S.H. Lee,
C.H. Hong,
M.K. Ju,
S.I. Kim
et al.
|
32-35
|
|
|
|
Kidney Grafts With Multiple Renal Arteries Is No Longer a Relative Contraindication With Advance in Surgical Techniques of Laparoscopic Donor Nephrectomy
Abstract: Objectives: Kidney grafts with multiple renal arteries were considered as a relative contraindication. We retrospectively reviewed our experience of kidney grafts with multiple renal arterie...
|
C.J. Hung,
Y.J. Lin,
S.S. Chang,
T.C. Chou,
P.C. Lee
et al.
|
36-38
|
|
|
|
Long-Term Outcomes of Living Kidney Donors Over the Past 28 Years in a Single Center in Taiwan
Abstract: Background: The chronic shortage of kidneys for transplantation has increased the number of living donations, but demand remains high, which has created a long waiting list of end-stage kidn...
|
S.-F. Tsai,
K.-H. Shu,
H.-C. Ho,
M.-J. Wu,
C.-H. Cheng,
J.-D. Lian,
M.-C. Wen,
C.-K. Su,
T.-M. Yu,
Y.-W. Chuang,
S.-T. Huang,
C.-H. Chen
et al.
|
39-42
|
|
|
|
Delayed Graft Function in Living-Donor Renal Transplantation: 10-Year Experience
Abstract: Background: Delayed graft function (DGF), a dialysis requirement within a week after transplantation, can occur in deceased-donor renal transplantation. DGF is rare, in living-donor renal tr...
|
H.S. Park,
Y.A. Hong,
H.G. Kim,
S.R. Choi,
I.O. Sun,
B.H. Chung,
B.S. Choi,
C.W. Park,
Y.S. Kim,
C.W. Yang
et al.
|
43-46
|
|
|
|
World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country
Abstract: Background: World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the ge...
|
P.R. Shah,
P.R. Modi,
V.B. Kute,
A.V. Vanikar,
H.V. Patel,
M.R. Gumber,
V.R. Shah,
H.L. Trivedi
et al.
|
47-48
|
|
|
|
99mTc-mercaptoacetyl Triglycine Renography to Monitor Renal Transplant Function Among Kidneys from Donors After Cardiac Death
Abstract: Purpose: Delayed graft function usually occurs after kidney transplantation from donors after cardiac death, It is important to monitor graft function during the anuric period, but there hav...
|
T. Majima,
R. Hattori,
Y. Funahashi,
T. Komatsu,
M. Kato,
S. Yamada,
O. Kamihira,
M. Goto
et al.
|
49-53
|
|
|
|
Kidney Transplantation Using Expanded Criteria Donors in Korea
Abstract: Background: Use of expanded criteria donor (ECD) grafts seeks to solve the organ shortage. We investigated the current status of donor selection and transplantation outcomes. Methods: We ret...
|
J.C. Jeong,
M.-G. Kim,
H. Ro,
Y.J. Kim,
H.C. Park,
H.Y. Kwon,
H.J. Jeon,
J. Ha,
C. Ahn,
J. Yang
et al.
|
54-56
|
|
|
|
Adult Dual Kidney Transplantations Obtained From Marginal Donors: Two Case Reports
Abstract: Organ shortage has led us to use grafts from expanded criteria donors (ECD). Dual kidney transplantation (DKT) using organs from an ECD, which are not acceptable for single kidney transplant...
|
Y.H. Kim,
J.H. Jung,
K.B. Song,
Y.S. Chung,
J.B. Park,
Y.M. Cho,
H.J. Jang,
S.-C. Kim,
D.J. Han
et al.
|
57-59
|
|
| Transplant Candidates |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Desensitizing the Broadly Human Leukocyte Antigen–Sensitized Patient Awaiting Deceased Donor Kidney Transplantation
Abstract: For broadly human leukocyte antigen–sensitized patients (HS; calculated panel-reactive antibody >80%), options for deceased donor (DD) transplantation are extremely limited. Data from Uni...
|
S.C. Jordan,
N. Reinsmoen,
C.-H. Lai,
K. Cao,
J. Kahwaji,
A. Peng,
R. Villicana,
A. Vo
et al.
|
60-61
|
|
|
|
Cytotoxic Flow Cytometric Crossmatch in Renal Transplantation: A Single Assay to Simultaneously Detect Antibody Binding and Cytotoxicity
Abstract: Objectives: The complement-dependent lymphocytotoxicity crossmatch (CDC-XM) detects cytotoxic parameters of preformed antibodies. The flow cytometric crossmatch (FCXM) is used to detect the ...
|
D. Thammanichanond,
W. Athimang,
K. Paisooksantivatana,
T. Mongkolsuk,
A. Ingsathit,
S. Worawichawong,
P. Kitpoka,
S. Jirasiritham,
S. Kantachuvesiri
et al.
|
62-65
|
|
|
|
Management of Patients on the Waiting List for Deceased Donor Kidney Transplantation
Abstract: Background: Although the number of wait-listed patients for deceased donor kidney transplantation has been continuously increasing in Korea, no standard guidelines exist for their management...
|
M.G. Kim,
H. Ro,
Y.J. Kim,
H.C. Park,
J.C. Jeong,
H.J. Jeon,
H. Kim,
M.W. Park,
K.-H. Oh,
Y.S. Kim,
C. Ahn,
J. Yang
et al.
|
66-71
|
|
|
|
Clinical Outcome of Renal Transplantation in End-Stage Renal Disease Patients With Positive Pretransplantation Hepatitis B Surface Antigen
Abstract: Background: Renal transplantation (RTx) is the best therapeutic modality for patient suffering from end-stage renal disease (ESRD) with positive pretransplantation hepatitis B surface antige...
|
H.V. Patel,
V.B. Kute,
A.V. Vanikar,
P.R. Shah,
M.R. Gumber,
S.H. Jain,
D.P. Engineer,
G.H. Ghelani,
H.L. Trivedi
et al.
|
72-74
|
|
|
|
Kidney Transplantation in Patients With Long-Term (More Than 15 Years) Prior Dialysis Therapy
Abstract: Objective: The number of kidney transplantations (KTx) among patients on long-term hemodialysis (HD) is increasing due to the donor shortage in Japan. We investigated the outcomes of KTx amo...
|
T. Kimura,
N. Ishikawa,
T. Fujiwara,
Y. Sakuma,
A. Nukui,
M. Yashi,
T. Yagisawa
et al.
|
75-76
|
|
|
|
Outcomes of Renal Transplantation After End-Stage Renal Disease Due to Diabetic Nephropathy: A Single-Center Experience
Abstract: Background: Diabetic nephropathy is the most common cause of end-stage renal disease (ESRD) worldwide. However, data on renal transplantation outcomes in diabetic nephropathy among Japanese ...
|
K. Tokodai,
N. Amada,
H. Kikuchi,
I. Haga,
T. Takayama,
A. Nakamura
et al.
|
77-79
|
|
|
|
Follow-up and Treatment of Renal Transplantation with Nephropathic Cystinosis in Central Taiwan
Abstract: Background: Cystinosis is a rare autosomal recessive disease caused by a defect in lysosomal cystine. The intracellular cystine accumulation causes damage in multiple organs and renal failur...
|
Y.-W. Chuang,
M.-C. Wen,
M.-J. Wu,
K.-H. Shu,
C.-H. Cheng,
T.-M. Yu,
S.-T. Huang,
C.-H. Chen
et al.
|
80-82
|
|
|
|
Renal Transplantation in Patients With Human T-Cell Lymphotropic Virus Type 1
Abstract: Background: Renal transplantation (RTx) in carriers of human T-cell lymphotropic virus type 1 (HTLV-1) has a risk of developing overt leukemia upon immunosuppression. Although there have bee...
|
H. Shirai,
M. Suzuki,
Y. Tomita,
K. Iwadoh,
K. Kai,
A. Sannomiya,
I. Koyama,
I. Nakajima,
S. Fuchinoue
et al.
|
83-86
|
|
|
|
Frequent False-Positive Reactions in Pronase-Treated T-Cell Flow Cytometric Cross-match Tests
Abstract: Objective: Pretransplantation cross-match (XM) is essential in organ transplantation. The flow cytometric XM (FCXM) is the most sensitive cell-based XM technique. Pronase treatment is used t...
|
H. Park,
Y.M. Lim,
B.Y. Han,
J. Hyun,
E.Y. Song,
M.H. Park
et al.
|
87-90
|
|
|
|
Renal Replacement Therapy: Available Information Versus Demands of Patients
Abstract: Objective: This study examined the current state of information on renal replacement therapy and the educational demands of kidney transplant recipients. Methods: The study was conducted thr...
|
D.J. Joo,
S. Son,
H.J. Kim,
J.E. Lee,
J.Y. You,
S.Y. Lee,
M.S. Kim,
S.I. Kim,
Y.S. Kim
et al.
|
91-93
|
|
| Immunosuppression |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Cyclosporine Microemulsion Formulation (Sigmasporin Microral) Effect as First-Line Immunosuppressant on Renal Functions at 3 Years
Abstract: Background: Cyclosporine (CsA) remains a mainstay of immunosuppressive maintenance regimens in developing countries, but its effects on long-term kidney allograft survival are still unclear....
|
J. Al Wakeel,
F.A.M. Shaheen,
A. Al Alfi,
E.H. Abbas Fagir,
A. Iman,
M.R.N. Nampoory,
M.S.A. Al Mousawi,
T. Said,
H. Abou Zeinab,
D.S. Shaker,
B.B. Ghaedi
et al.
|
94-100
|
|
|
|
Safety and Efficacy of Generic Cyclosporine Arpimune in Filipino Low-Risk Primary Kidney Transplant Recipients
Abstract: Background: In the Philippines, maintenance of immunosuppression may not always be affordable, leading to acute rejection and graft loss. The availability of the generic cyclosporine Arpimun...
|
G.E.P. Pamugas,
R.A. Danguilan,
A.B. Lamban,
V.B. Mangati,
E.T. Ona
et al.
|
101-108
|
|
|
|
Impact of Cytochrome P450 3A and ATP-Binding Cassette Subfamily B Member 1 Polymorphisms on Tacrolimus Dose-Adjusted Trough Concentrations Among Korean Renal Transplant Recipients
Abstract: Background: Tacrolimus is a substrate of cytochrome P450 3A (CYP3A) and P-glycoprotein (P-gp), encoded by the CYP3A and ATP-binding cassette subfamily B member 1 (ABCB1) genes, respectively....
|
J.-H. Cho,
Y.-D. Yoon,
J.-Y. Park,
E.-J. Song,
J.-Y. Choi,
S.-H. Yoon,
S.-H. Park,
Y.-L. Kim,
C.-D. Kim
et al.
|
109-114
|
|
|
|
A 39-Month Follow-up Study to Evaluate the Safety and Efficacy in Kidney Transplant Recipients Treated With Modified-Release Tacrolimus (FK506E)-Based Immunosuppression Regimen
Abstract: Background: We initially performed a study to evaluate the safety and efficacy of modified-release tacrolimus (FK506E) in a phase 3, 2-arm, 6-month, randomized, open-label, multicenter trial...
|
D.J. Han,
J.B. Park,
Y.S. Kim,
S.J. Kim,
J. Ha,
H.-C. Kim,
S.-J. Kim,
I.-S. Moon,
C.-W. Yang
et al.
|
115-117
|
|
|
|
Effect of Conversion From Twice-daily to Once-daily Tacrolimus on Glucose Intolerance in Stable Kidney Transplant Recipients
Abstract: Background: Tacrolimus is an established immunosuppressant for the prevention and treatment of allograft rejection in organ transplantation. However, tacrolimus therapy also has several adve...
|
T. Tsuchiya,
K. Ishida,
S. Ito,
T. Deguchi
|
118-120
|
|
|
|
A Switch From Conventional Twice-Daily Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Kidney Transplant Recipients
Abstract: Background: Extended-release tacrolimus (TAC-ER) was developed to provide a more convenient treatment compliance and improve safety by avoiding toxic peak levels. We prospectively evaluated ...
|
S. Hatakeyama,
T. Fujita,
T. Yoneyama,
T. Yoneyama,
T. Koie,
Y. Hashimoto,
H. Saitoh,
T. Funyu,
S. Narumi,
C. Ohyama
et al.
|
121-123
|
|
|
|
Safety and Efficacy of Conversion from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Graceptor) in Stable Kidney Transplant Recipients
Abstract: Background: Graceptor is a new modified-release once-daily formulation of tacrolimus with an efficacy and safety profile similar to twice-daily tacrolimus (Prograf), as identified by clinica...
|
Y. Nakamura,
K. Hama,
H. Katayama,
A. Soga,
T. Toraishi,
T. Yokoyama,
Y. Kihara,
Y. Jojima,
O. Konno,
H. Iwamoto,
H. Takeuchi,
T. Hirano,
M. Shimazu
et al.
|
124-127
|
|
|
|
Conversion of Stable Kidney Transplant Recipients From a Twice-Daily Prograf to a Once-Daily Tacrolimus Formulation: A Short-Term Study on its Effects on Glucose Metabolism
Abstract: Background: The adverse effects of tacrolimus are known to play major roles in posttransplantation diabetes mellitus (PTDM). In the present study, we investigated the effects of conversion f...
|
J. Uchida,
N. Kuwabara,
Y. Machida,
T. Iwai,
T. Naganuma,
N. Kumada,
T. Nakatani
et al.
|
128-133
|
|
|
|
Falsely Abnormally Elevated Blood Trough Concentration of Tacrolimus Measured by Antibody-Conjugated Magnetic Immunoassay in a Renal Transplant Recipient: A Case Report
Abstract: This report presents a falsely abnormally elevated blood trough concentration (Ct) of tacrolimus measured by antibody-conjugated magnetic immunoassay (ACMIA) methods in a renal transplant re...
|
T. Toraishi,
H. Takeuchi,
Y. Nakamura,
O. Konno,
T. Yokoyama,
H. Iwamoto,
K. Hama,
T. Hirano,
S. Unezaki,
K. Okuyama,
M. Shimazu
et al.
|
134-136
|
|
|
|
Cyclosporine or Tacrolimus: Which Is the Better Partner for Myfortic or CellCept?
Abstract: Background: Mycophenolic acid (MPA) pharmacokinetics using the mycophenolate mofetil (CellCept) formulation are known to differ between patients receiving tacrolimus (FK) or cyclosporine (Cy...
|
P.-C. Lee,
S.-S. Chang,
S.-C. Shieh,
Z.-C. Wu,
W.-M. Wang,
J.-D. Wang,
C.-J. Hung,
Y.-J. Lin,
T.-C. Chou,
R.-H. Chan
et al.
|
137-139
|
|
|
|
The Efficacy and Safety of High-Dose Mizoribine in ABO-Incompatible Kidney Transplantation Using Anti-CD20 and Anti-CD25 Antibody Without Splenectomy Treatment
Abstract: Background: Mizoribine (MZR) has been developed as an immunosuppressive agent in Japan, but it shows less potent immunosuppressive effects at doses up to 3 mg/kg/d. In this study, we investi...
|
N. Yoshimura,
H. Ushigome,
M. Matsuyama,
S. Nobori,
T. Suzuki,
K. Sakai,
H. Okajima,
M. Okamoto
et al.
|
140-143
|
|
|
|
A 6-Month, Open-Label, Multicenter Clinical Study in Korean De Novo Renal Transplant Patients Evaluating the Efficacy, Safety, and Tolerance of Myfortic Concomitantly Used with Tacrolimus
Abstract: Enteric-coated mycophenolate sodium (Myfortic, Novartis Pharma AG, Basel, Switzerland) is designed to improve the gastrointestinal tolerability of micophenolic acid. This study was designed ...
|
M.K. Ju,
S.H. Park,
S.J. Kim,
I.S. Moon,
Y.S. Kim
et al.
|
144-146
|
|
|
|
Excellent Results With High-Dose Mizoribine Combined With Cyclosporine, Corticosteroid, and Basiliximab in Renal Transplant Recipients: Multicenter Study in Japan
Abstract: We performed a multicenter study in Japan to assess the efficacy and safety of immunosuppressive therapy with high-dose mizoribine (MZR; 6 mg/kg) combined with basiliximab (Bas), cyclosporin...
|
K. Nishimura,
K. Uchida,
K. Yuzawa,
Y. Fukuda,
Y. Ichikawa,
K. Akioka,
M. Fujisawa,
A. Sugitani,
S. Ito,
T. Nakatani,
T. Horimi,
N. Yoshimura
et al.
|
147-149
|
|
|
|
Experiences of High-Dose Mizoribine as Antimetabolite Immunosuppressants for Kidney Transplantation
Abstract: We have used low doses of mizoribine (MZ) or mycophenolate mofetil (MMF) as induction and maintenance immunosuppressants, but since 2009 have employed a high dose of MZ. We reviewed the effi...
|
N. Nakamura,
H. Mikami,
H. Matsuoka,
S. Irie,
Y. Abe,
Y. Sasatomi,
S. Ogawara,
T. Saitoh,
M. Tanaka
et al.
|
150-153
|
|
|
|
Everolimus with Reduced-dose Cyclosporine Versus Full-dose Cyclosporine and Mycophenolate in De Novo Renal Transplant Patients: A 2-Year Single-Center Experience
Abstract: Background: Although calcineurin inhibitors (CNIs) has improved short-term graft survival, long-term function remains a challenge. CNIs have been implicated in the development of chronic all...
|
S.M. Santos,
C.M. Carlos,
C.B. Cabanayan-Casasola,
R.A. Danguilan
|
154-160
|
|
|
|
Sirolimus-Induced Pneumonitis After Renal Transplantation: A Single-Center Experience
Abstract: Purpose: Sirolimus is a potent immunosuppressive agent used with increasing frequency in kidney transplantation. However, sirolimus can increase the rate of unexplained interstitial pneumoni...
|
H.S. Lee,
K.H. Huh,
Y.S. Kim,
M.S. Kim,
H.J. Kim,
S.I. Kim,
D.J. Joo
et al.
|
161-163
|
|
|
|
Induction Therapy by Anti-Thymocyte Globulin (Rabbit) Versus Basiliximab in Deceased Donor Renal Transplants and the Effect on Delayed Graft Function and Outcomes
Abstract: The use of induction therapy significantly reduces the incidence of acute rejection (AR) episodes posttransplantation and prevents delayed graft function (DGF). In our program, all adult dec...
|
C.E. Foster,
R.R. Weng,
M. Piper,
K. Laugenou,
H. Ichii,
J. Lakey,
D. Malinoski
et al.
|
164-166
|
|
|
|
Rabbit Antithymocyte Globulin Compared with Basiliximab in Kidney Transplantation: A Single-Center Study
Abstract: Background: Induction therapy is used to reduce the incidence of acute rejection and to prevent or treat delayed graft function. We compared basiliximab with rabbit antithymocyte globulin (A...
|
J.M. Kim,
H.R. Jang,
C.H.D. Kwon,
W.S. Huh,
G.S. Kim,
S.J. Kim,
J.W. Joh,
H.Y. Oh
et al.
|
167-170
|
|
|
|
Comparison Between Thymoglobulin and ATGAM as an Induction Agent in Adult Kidney Transplantation: A Single-Center Experience
Abstract: Objective: The best antithymocyte globulin (ATG) preparation for induction suppression in kidney transplant recipients is still not clear. The aim of this study was to identify short- and lo...
|
J.M. Kim,
H.R. Jang,
J.S.W. Ko,
C.H.D. Kwon,
M.S. Kwak,
W.S. Hur,
S.J. Kim,
G.S. Kim,
J.-W. Joh,
S.-K. Lee,
H.Y. Oh
et al.
|
171-174
|
|
|
|
Impact of Basiliximab on the Proportion of Regulatory T Cells and Their Subsets Early After Renal Transplantation: A Preliminary Report
Abstract: Object: This study aims to investigate the impact of anti-CD25 monoclonal antibody (basiliximab) on peripheral blood regulatory T cells (Treg) and their subsets in recipients early after ren...
|
T. Zhao,
C. Yang,
Y. Xue,
Y.Y. Qiu,
L. Hu,
Y. Qiu,
X. Wang,
B. Yang,
R. Rong,
M. Xu,
T. Zhu
et al.
|
175-178
|
|
|
|
Early Steroid Withdrawal in Adult Kidney Transplantation at a Single Center
Abstract: Background: Beneficial effects of protocols using minimal steroid exposure have been recently reported. The purpose of this study was to evaluate the outcomes of kidney transplantation recip...
|
H. Iwamoto,
K. Hama,
O. Konno,
T. Yokoyama,
Y. Kihara,
Y. Jojima,
Y. Nakamura,
H. Takeuchi,
M. Shimazu
et al.
|
179-181
|
|
|
|
Effectiveness of Rituximab and Intravenous Immunoglobulin Therapy in Renal Transplant Recipients with Chronic Active Antibody-Mediated Rejection
Abstract: Background: Chronic active antibody-mediated rejection (CAMR) is an important cause of chronic kidney allograft dysfunction, but there has been no effective treatment protocol established fo...
|
Y.A. Hong,
H.G. Kim,
S.R. Choi,
I.O. Sun,
H.S. Park,
B.H. Chung,
B.S. Choi,
C.W. Park,
Y.S. Kim,
C.W. Yang
et al.
|
182-184
|
|
|
|
Trends in the Use of Immunosuppressive Agents by Outpatients After Renal Transplantation at a Medical Center in Southern Taiwan
Abstract: Kidney transplantation has become an effective treatment for end-stage renal failure. This study analyzed trends in immunosuppressive agent use after renal transplantation at a medical cente...
|
P.C.-M. Mao,
E.K.-L. Lee,
P.-L. Tseng
|
185-189
|
|
|
|
Trends in Maintenance Immunosuppressive Drugs Used in Taiwanese Kidney Transplant Recipients: An Analysis of the National Health Insurance Research Database
Abstract: Trends in maintenance immunosuppressive drugs used among Taiwanese kidney transplant recipients have not been reported before. We examined the National Health Insurance Research Database to ...
|
S.-F. Tsai,
C.-Y. Cheng,
K.-H. Shu,
M.-J. Wu
|
190-192
|
|
| Outcomes |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Successful Transplantation Across Positive B-Cell Cross-Match in Deceased Donor Renal Transplants
Abstract: A positive T-cell cross-match is a well-established contraindication to deceased donor renal transplantation (DDRT); however, the significance of a positive B-cell cross-match (BCXM) remains...
|
A. Goh,
E. Oei,
A. Vathsala
|
193-199
|
|
|
|
Successful Kidney Transplantation After Desensitization Using Plasmapheresis, Low-Dose Intravenous Immunoglobulin, and Rituximab in Highly Sensitized Patients: A Single-Center Experience
Abstract: Background: For many highly allosensitized renal transplant candidates, an acceptable donor is never identified, and the patient remains on dialysis indefinitely. In an attempt to ameliorate...
|
M.-K. Jin,
J.-H. Cho,
O. Kwon,
K.-D. Hong,
J.-Y. Choi,
S.-H. Yoon,
S.-H. Park,
Y.-L. Kim,
C.-D. Kim
et al.
|
200-203
|
|
|
|
Excellent Outcomes of ABO-Incompatible Kidney Transplantation: A Single-Center Experience
Abstract: Introduction: Due to the severe shortage of deceased donors in Japan, ABO-incompatible living donor kidney transplantation has been performed since the late 1980s. Excellent long-term outcom...
|
J. Uchida,
N. Kuwabara,
Y. Machida,
T. Iwai,
T. Naganuma,
N. Kumada,
T. Nakatani
et al.
|
204-209
|
|
|
|
Potent Immunosuppression for ABO-Incompatible Renal Transplantation May Not Be a Risk Factor for Malignancy
Abstract: ABO-incompatible (ABOi) renal transplantation has been increasing, but malignant tumor is a troubling complication of kidney transplantation due to potent immunosuppression. Few previous stu...
|
T. Yamamoto,
T. Kawaguchi,
Y. Watarai,
M. Tujita,
T. Hiramitsu,
K. Nanmoku,
N. Goto,
A. Katayama,
T. Kobayashi,
K. Uchida
et al.
|
210-213
|
|
|
|
Outcomes of Pediatric ABO-Incompatible Kidney Transplantations Are Equivalent to ABO-Compatible Controls
Abstract: Background: Due to the profound shortage of suitable deceased allografts, much effort has been made to investigate whether successful kidney transplantation (KT) is possible across the ABO b...
|
S. Shishido,
Y.Y. Hyodo,
Y. Aoki,
J. Takasu,
T. Kawamura,
K.K. Sakai,
A.A. Aikawa,
H. Satou,
M.M. Muramatsu,
Z. Matsui
et al.
|
214-216
|
|
|
|
The Correlation of HLA Allele Frequencies and HLA Antibodies in Sensitized Kidney Transplantation Candidates
Abstract: Background: The clinical importance of the HLA system is as a transplant antigen. However, correlations between the development and strength of the immune response and HLA genes or specific ...
|
Q. Fu,
C. Wang,
W. Zeng,
L. Liu
|
217-221
|
|
|
|
Effects of Different Sensitization Events on HLA Alloimmunization in Solid Organ Transplantation Patients
Abstract: Objective: HLA alloimmunization is caused by various sensitization events, such as transfusion, pregnancy, or organ transplantation. However, the effects of a particular sensitization event ...
|
J. Hyun,
K.D. Park,
Y. Yoo,
B. Lee,
B.Y. Han,
E.Y. Song,
M.H. Park
et al.
|
222-225
|
|
